Vorasidenib: A narrative drug review
Isocitrate dehydrogenase (IDH) mutations (IDH1 and IDH2) are observed in malignancies such as low-grade gliomas, acute myeloid leukemia, cholangiocarcinoma, and chondrosarcoma. Vorasidenib is a targeted therapy for IDH-mutant gliomas that significantly delays disease progression and the need for add...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2025-10-01
|
| Colecção: | Cancer Research, Statistics, and Treatment |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/crst.crst_46_25 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|